Cargando…

Clinical advances in epigenetic therapies for lymphoma

BACKGROUND: Advances in understanding of cancer biology, genomics, epigenomics, and immunology have resulted in development of several therapeutic options that expand cancer care beyond traditional chemotherapy or radiotherapy, including individualized treatment strategies, novel treatments based on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenthal, Allison C., Munoz, Javier L., Villasboas, J. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985856/ https://www.ncbi.nlm.nih.gov/pubmed/36871057 http://dx.doi.org/10.1186/s13148-023-01452-6

Ejemplares similares

Recent advances in the management of Hodgkin lymphoma
por: Villasboas, Jose C., et al.
Publicado: (2016)

Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider’s Perspective
por: Granroth, Ginna, et al.
Publicado: (2022)

Primary Effusion Lymphoma: A Clinicopathologic Perspective
por: Gathers, Diamone A., et al.
Publicado: (2022)

Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma
por: Zhang, Ping, et al.
Publicado: (2020)

Advances in epigenetic glioblastoma therapy
por: Lee, Dong Hoon, et al.
Publicado: (2017)

Advances in Ophthalmic Epigenetics and Implications for Epigenetic Therapies: A Review
por: Moore, Spencer M., et al.
Publicado: (2023)

Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma
por: Saifi, Omran, et al.
Publicado: (2023)

Epigenetics of Cutaneous T-Cell Lymphomas
por: Hara, Natsumi, et al.
Publicado: (2022)

Epigenetic Alterations in Canine Malignant Lymphoma: Future and Clinical Outcomes
por: Montaner-Angoiti, Esperanza, et al.
Publicado: (2023)

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
por: Cheng, Yuan, et al.
Publicado: (2019)

Radiation Therapy for Advanced-Stage Hodgkin Lymphoma
por: Lockney, Natalie A., et al.
Publicado: (2020)

Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
por: Alkhateeb, Hassan B., et al.
Publicado: (2022)

Advances in targeted therapy for malignant lymphoma
por: Wang, Li, et al.
Publicado: (2020)

Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics
por: García-Domínguez, Daniel J., et al.
Publicado: (2022)

Copanlisib for the Treatment of Malignant Lymphoma: Clinical Experience and Future Perspectives
por: Munoz, Javier, et al.
Publicado: (2021)

A Promising Future for Precision Epigenetic Therapy for Follicular and Diffuse Large B-Cell Lymphoma?
por: Chung, Clement
Publicado: (2022)

Advanced Hodgkin Lymphoma: a New Era of Therapy
por: Dann, Eldad J.
Publicado: (2014)

Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma
por: Mohammed Saleh, Mostafa F., et al.
Publicado: (2021)

Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma
por: Ribeiro, Marcelo L., et al.
Publicado: (2019)

Epigenetic targets in B- and T-cell lymphomas: latest developments
por: Ribeiro, Marcelo Lima, et al.
Publicado: (2023)

The Role of Epigenetic Modifier Mutations in Peripheral T-Cell Lymphomas
por: Tigu, Adrian-Bogdan, et al.
Publicado: (2023)

Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials
por: Lai, Pan, et al.
Publicado: (2021)

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma
por: Wiedmeier-Nutor, Julia Erin, et al.
Publicado: (2022)

Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review
por: Smith, Haller J., et al.
Publicado: (2017)

Epigenetic advances in clinical neuroscience
por: Abel, Ted, et al.
Publicado: (2014)

The Advances in Epigenetics for Cancer Radiotherapy
por: Wang, Yuexuan, et al.
Publicado: (2022)

Modulating epigenetic modifications for cancer therapy (Review)
por: Castro-Muñoz, Leonardo Josué, et al.
Publicado: (2023)

An Update on Recent Advances of Photodynamic Therapy for Primary Cutaneous Lymphomas
por: Liu, Wei-Ting, et al.
Publicado: (2023)

PET-adapted approaches to primary therapy for advanced Hodgkin lymphoma
por: Lang, Noemie, et al.
Publicado: (2020)

Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma
por: Klener, Pavel
Publicado: (2019)

Advances in Understanding of Metabolism of B-Cell Lymphoma: Implications for Therapy
por: Kluckova, Katarina, et al.
Publicado: (2022)

Recent advances in CAR T-cell therapy for lymphoma in China
por: Che, Yuxuan, et al.
Publicado: (2023)

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma
por: Wiedmeier, Julia E., et al.
Publicado: (2021)

Epigenetic therapy in urologic cancers: an update on clinical trials
por: Faleiro, Inês, et al.
Publicado: (2016)

Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
por: Nepali, Kunal, et al.
Publicado: (2021)

P1215: CHARACTERIZATION AND CLINICAL SIGNIFICANCE OF T FOLLICULAR HELPER SUBSETS IN FOLLICULAR LYMPHOMA
por: Yang, Zhi-Zhang, et al.
Publicado: (2023)

CAR-T Therapy in Lymphoma Patients With Coexisting Cardiomyopathy or Cardiac Lymphomatous Involvement
por: Ng, Choon Ta, et al.
Publicado: (2023)

Barriers to enrollment in clinical trials of patients with aggressive B-cell NHL that progressed after CAR T-cell therapy
por: Bezerra, Evandro D., et al.
Publicado: (2022)

Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
por: Wu, Yan-Lin, et al.
Publicado: (2023)

Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials
por: Shi, Yuncong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3vhh5ibb1svp5o7ocuv51gve4c